Search
site map
IP Handbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
About
MIHR
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
JACOBY, Erica
Erica Jacoby, a senior commercialization associate in PATH’s Technology Solutions Strategic Program, serves as a resource in the general areas of business planning, market development, and commercialization activities. Her primary responsibilities include identifying, conducting due diligence, and selecting partners; conducting market assessments; developing commercialization strategies; and writing and negotiating legal agreements. In these capacities, she is involved with several different technology development projects at PATH, including needle-free injections, vitamin-fortified rice, neonatal resuscitators, and HIV/STI prevention technologies such as the female condom. Prior to joining PATH, Ms. Jacoby worked in marketing and research at several organizations, including a diagnostic test manufacturer, the Institute of the Americas, and the Graduate School of International Relations/Pacific Studies at the University of California, San Diego (UCSD). Her overseas experience includes work and study in Mexico, Slovakia, Spain, and Venezuela. She holds a Master’s degree in Pacific international affairs, with a concentration in international management, from the University of California, San Diego.
Abstract
How Public–Private Partnerships Handle Intellectual Property: The PATH Experience
Abstract:
PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public and private sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH’s work improves global health and well-being. Over the past 28 years, PATH has demonstrated that public–private partnerships (PPPs) can effectively address unmet public health needs, particularly when managed with a clear understanding of both public and private sector objectives. Indeed, collaboration between public sector and private sector partners is an especially valuable way to develop and advance appropriate health technologies for use in developing countries. When developing and managing PPPs, PATH recognizes that intellectual property (IP) is an especially important component in the range of variables that affect the economic, technical, and programmatic feasibility of a new health technology intervention. Our goal, therefore, is to incorporate IP considerations as a fundamental part of the PPP process. We seek to manage IP strategically to avoid or quickly overcome any IP-related roadblocks. Using three case studies, this chapter illustrates PATH’s strategies for private sector collaboration, as well as PATH’s approaches to managing IP.
|